EFL026 - RAI for Metastatic Thyroid Cancer

Join host Chase Hendrickson, MD, from Vanderbilt Unviersity Medical Center as he discusses a recent article in Journal of the Endocrine Society (JES) with Imali Sirisena, MD, from Temple University and Mike Tuttle, MD, from Memorial Sloan Kettering Cancer Center. The article is from the March 2022 edition of JES: “Metastatic Differentiated Thyroid Cancer Survival Is Unaffected by Mode of Preparation for 131I Administration.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series